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Abstract
Background: Stroke is a heterogeneous, multifactorial disease regulated by modifiable and non-modifiable risk factors like 
total cholesterol, triglycerides, high density lipid-cholesterol (HDL-C), low density lipid-cholesterol (LDL-C) and glucose and 
non-modifiable factors like age. Evaluation of  these risk factors for ischemic stroke may contribute to more effective prevention. 
Methods: This meta-analysis investigated the data up to 2018 with respect to age, total cholesterol, triglycerides, high density 
lipid-cholesterol (HDL-C), low density lipid-cholesterol (LDL-C) and glucose levels in the Ischemic stroke patients and controls. 
Data from each eligible study was extracted such as year of  publication, first author name, ethnicity/country, number of  isch-
emic stroke patients and healthy controls and studies were subjected to heterogeneity analysis. 
Results: Meta-analysis of  the modifiable and non-modifiable risk factors like total cholesterol, HDL-C and LDL-C glucose, 
triglycerides levels and age were not having significantly  associated with ischemic stroke (p>0.05).  However meta-analysis of  
triglyceride yielded significant association ischemic stroke with overall 95% CI (-0.62- (-0.09) and P= 0.007 and glucose also 
showed significant association with ischemic stroke with 95% CI (-1.08- (-0.14), P=0.01. Studies were subjected to heterogeneity 
which revealed significant heterogeneity with (P<0.00) and I2>96%. 
Conclusion: Meta-analysis revealed that levels of  triglyceride and glucose are the predisposing factors for ischemic stroke in 
the Asian population.   
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Ischemic stroke accounts for about 80 % of  the stroke 
population1 and is a leading cause of  mortality, presents 
a serious threat to public health2,3. Most strokes occur in 
people older than 70 years, rarely occuring in those below 
35 years old4,5.  Ischemic stroke is a multi-factorial disor-
der6. A number of  risk factors are associated with an in-
creased risk of  stroke. They can be stratified into modifi-
able and non-modifiable risk factors. It is widely accepted 
that stroke increases dramatically with age and it is more 
likely to affect the elderly. Ischemic stroke is no longer a 
disease affecting just elderly people, one-fourth of  isch-
emic strokes occurs in working-aged individuals and an 
estimated 3.6 million young people are affected each year. 
Approximately 10% of  ischemic strokes occur in people 
aged less than 50 years7,8. Ischemic stroke at young age 
may be increasing further, since multiple recent studies 
have reported increasing incidence of  ischemic strokes 
particularly at younger ages since 1980s, while incidence 
at older ages has been declining during the same peri-
od9-13. Higher stroke rates are noted in African Americans, 
Hispanic Americans and the Black race compared to the 
White one. In addition to common risk factors such as 
hypertension, diabetes, and smoking, recent studies have 
shown that genetic factors have important roles in the 
pathogenesis of  ischemic stroke14,15. Higher prevalence 
of  stroke is noted in Chinese and Japanese population4,5. 
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Thus identification and management of  possible risk fac-
tors to prevent stroke is an important strategy to reduce 
human and economic burden of  ischemic stroke5. 
This review discusses and summarizes the evidence for 
modifiable and non-modifiable risk factors in ischemic 
stroke and their association on Asian population.  
Methodology 
Data identification and extraction 
We searched the PubMed, Google, MEDLINE, CNKI, 
VIP INFORMATION and Embase databases were 
searched up to April 2018 using ischemic stroke to iden-
tify all relevant literature on human studies. Furthermore, 
we searched the reference lists of  reviews and retrieved 
articles manually. When the same patient population ap-
peared in several publications, we chose the largest sample 
size. Data from each eligible study was extracted such as 
year of  publication, first author name, ethnicity/country, 
number of  ischemic stroke patients and healthy controls, 
modifiable and non-modifiable risk factors and reported 
associations. This meta-analysis included a total of  08 ar-
ticles on modifiable and non-modifiable risk factors and 
ischemic stroke. Data were extracted independently from 
each study by using a pre-defined form and disagree-
ments were resolved by discussion.
Inclusion criteria 
The selected studies met the following criteria: well-de-
signed case-control studies to evaluate the modifiable and 
non-modifiable factors and ischemic stroke risk.
Exclusion criteria
Studies were excluded if  one of  the following existed: 
non-Asian population; animal studies, reviews, case re-
ports, abstracts and family-based studies.
Statistical analysis
Comprehensive meta-analysis (CMA) V.3 was employed 
for calculation of  pooled standard errors and 95% con-
fidence interval (CIs). The standard differences in means 
were estimated for each study in a random-effect mod-
el. A chi-square-based Q test was used to measure be-
tween-study heterogeneity. Statistical significance was 
defined at P < 0.01. In addition, I2 statistic was calcu-
lated to quantify the proportion of  the total variation 
across studies due to heterogeneity (I2 = 0%-25%: no 
heteroge¬neity; I2= 25-50%: moderate heterogeneity; 
I2=50-75%: large heterogeneity; I2= 75-100%: extreme 
heterogeneity)16. The ORs were pooled using the fixed 
effects model (Mantel-Haenszel method)17 when P>0.01 
and the random effects model (Der Simonian and Laird 
method)18 if  P<0.01. Meta-analysis of  the present stud-
ies yielded I2 values of  >95%, thus indicate significant 
heterogeneity. Subgroup analysis by ethnicity and sample 




A total of  sixty-five papers were obtained by the publica-
tion search, among which eight met the inclusion criteria 
all in English (Fig 1). Eight meta-analyzed studies con-
ducted in different parts of  the world comparing modi-
fiable and non-modifiable risk factors in ischemic stroke 
patients and healthy controls. After detailed evaluation 
of  titles, abstracts and careful study of  papers/articles, 
08 eligible articles were screened for the meta-analysis, 
including 2611 confirmed ischemic stroke patients and 
2833 healthy controls. The characteristics of  the selected 
studies of  cases and controls are shown in Table 1. The 
Q test and I2 statistics revealed heterogeneity among the 
included studies and thus a random-effects model was 
employed in analysis of  all the modifiable and non-modi-
fiable risk factors. Hence following risk factors were eval-
uated in ischemic patients and healthy controls to find out 
the overall association of  the risk factors with ischemic 
patients.  
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Table 1: The main characteristics of studies selected for meta-analysis and distribution of modifiable and non-modifiable risk factors in Ischemic stroke 
patients and healthy controls  






Age* Total  
Cholesterol* 
Triglyceride* HDL-C* LDL-C* Glucose* Age* Total 
Cholesterol* 
Triglyceride* HDL-C* LDL-C* Glucose* 
ZHONG et al. 
(2017) 
(300/300) 
China 65.49 4.4 1.76 1.24 2.45 - 67.12 5.18 1.57 1.18 2.66 - 
Ming-Song et al.  
(2009) 
(100/270) 
Taiwan 70 187.14 141.32 41.06 117.9 119.43 63 183.28 105.39 42.63 124.55 109.81 
Minjie Shao et 
al. (2013) 
(459/462) 
China  68.56 4.73 1.79   2.91 - 63.82 4.86 1.79   3.03 - 
Wu et al. (2017)  
(167/176)  
Mongolia 57.5 5.11 2.13 1.39 3.08 - 50.99 7.97 2.24 1.45 3.08 - 
Hua-Tuo et al. 
(2017) 
(380/450) 
China 60.7 5.29 2.09 1.31 2.98 - 63.9 4.86 1.54 1.69 2.31 - 
Hong Li et al. 
(2017) 
(385/362) 
China 62.3 5.35 1.89 1.35 3.08 6.25 69.01 5.4 1.62 1.48 2.85 5.93 
Satrupa et al. 
(2018) 
(620/620) 
India 51.3 194.2 173.4 49.5   135.7 49.08 195.8 138.2 59.3 - 119.4 
Murali et al. 
(2014) 
(200/193) 
India 57.5 207.8 195.4 43.7 130 154.1 56 170.4 150.9 37.2 97.4 106.2 
 
* Mean values  
HDL-C=high density lipid-cholesterol 
LDL-C= low density lipid-cholesterol 
Age=Years 
Total Cholesterol, Triglyceride, HDL-C, LDL-C= mmol/l 
Glucose =mg/dl 
Fig 1: Flow chart
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Triglyceride 
The levels of  triglyceride were evaluated in 2611 con-
firmed ischemic stroke patients and 2833 controls. 
Overall data revealed significant heterogeneity Q=160, 
I2=95.62%, P=0.00 shown in Table 2. Meta-analysis by 
Random- effects model showed significant association of  
triglyceride with ischemic stroke with pooled standard er-
ror=0.13 (-0.62-(-0.09), Z=-2.65, P=0.007 as shown in 
Fig 2. 
 
Table 2: Statistics to test publication bias and heterogeneity in the meta-analysis 
Number 
of studies  
Genotype 
(Case/Control) 
Effect size and 95% interval Heterogeneity analysis  
Std. 
Error 





 (% ) 
08 Age  
(2611/2833) 
0.15  (-0.36-0.25)  -0.34 0.72 218.04  0.00 96.78 
08 Total Cholesterol  
(2611/2833) 
0.13  (-0.27-0.24) -0.09 0.92 154.47  
  
0.00 95.46 
08 Triglyceride  
(2611/2833) 
0.13  (-0.62- (-0.09)  -2.65 0.008 160.00  0.00 95.62 
07 HDL-C  
(2152/2371) 
0.18  (-0.20-0.53) 0.85 0.39 219.12  0.00 97.26 
07 LDL-C  
(1991/2213) 
0.15 (-0.44-0.14) -1.00 0.31 134.30  0.00 95.53 
04 Glucose 
(1305/1445) 
0.23 (-1.08- (-0.14) -2.56 0.01 96.33  0.00 96.88  
 
CI=confidence interval; Chi2 Q-statistic for homogeneity in Random-effects model aP-value for the Q-statistic in random-effect model 
bHiggins I2-statistic for heterogeneity in random-effect model  
HDL-C=high density lipid-cholesterol 
LDL-C= low density lipid-cholesterol 
Age=Years 
Total Cholesterol, Triglyceride, HDL-C, LDL-C= mmol/l 
Glucose =mg/dl 
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Total Cholesterol 
Total cholesterol was analyzed in 2611 ischemic stroke 
patients and 2833 controls and a significant heterogene-
ity was observed with Q=154.47, I2=95.46%, P=0.00 
shown in Table 2. Meta-analysis of  the above mentioned 
samples showed non-significant association of  total cho-
lesterol with ischemic stroke having pooled standard er-
ror=0.13 (-0.27-0.24), Z=-0.09, P=0.92 shown in Fig 2. 
High density lipid-cholesterol (HDL-C)
Ratio of  ischemic stroke patients andcontrols with re-
spect to high density lipid-cholesterol (HDL-C) was 
2152/2371. There was significant heterogeneity with 
Q=219.12, I2=97.26%, P=0.00 shown in Table 2. Me-
ta-analysis of  the high density lipid-cholesterol (HDL-C) 
levels between ischemic stroke patients and healthy con-
trols showed non-significant results with pooled standard 
error=0.18 (-0.20-0.53), Z=0.85, P=0.39 shown in Fig 3. 
Fig 2: Forest plots showing effect of triglycerides and total cholesterol on ischemic stroke.
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Low density lipid-cholesterol (LDL-C)
Ratio of  ischemic stroke patients and controls with re-
spect to low density lipid-cholesterol (LDL-C) was 
1991/2213. There was significant heterogeneity with 
Q=134.30, I2=95.53%, P=0.00 shown in Table 2. Me-
ta-analysis of  low density lipid-cholesterol (LDL-C) lev-
els between ischemic stroke patients and healthy controls 
showed non-significant results with pooled standard er-
ror =0.15 (-0.44-0.14), Z=-1.00, P=0.31 as shown Fig 3.  
Glucose
Ratio of  ischemic stroke patients and controls were 
1305/1445. There was significant heterogeneity Q=96.33, 
I2=96.88%, P=0.00 shown in Table 2. Meta-analysis 
of  glucose levels between ischemic stroke patients and 
healthy controls showed significant results with pooled 
standard error =0.23 (-1.08- (-0.14), Z=-2.56, P=0.01 as 
shown in Fig 4.    
Age
2611 ischemic stroke patients and 2833 controls with 
respect to age were analyzed for heterogeneity and sig-
nificant heterogeneity among studies was observed with 
Q=218.04, I2=96.78%, P=0.00 as indicated in Table 2. 
Meta-analysis of  the age in all cases and controls revealed 
non-significant results with pooled standard error=0. 15 
(-0.36-0.25), Z= -0.34, P=0.72 as shown in Fig 4. 
Fig 3: Forest plots showing effect of High Density Lipid- Cholesterol (HDL-C) and Low Density Lipid- Cholesterol (LDL-C) on ischemic stroke.
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Discussion
This present meta-analysis was undertaken to ascertain 
the role of  modifiable and non-modifiable risk factors on 
ischemic stroke in Asian population. Therefore relevant 
data was searched on ischemic stroke viz-a-viz modifiable 
and non-modifiable risk factors. By comparing the results 
published before and in the present study, we found great 
interest in the present meta-analysis. 
 
In a systematic review of  cohort studies with ischemic 
stroke sub-type specific follow-up data on death and re-
current stroke19 the risk of  a lacunar recurrence following 
a lacunar event at baseline was twice as great as the risk of  
lacunar recurrence following a non-lacunar event at base-
line.  Hypertension and diabetes were significant factors 
associated with recurrent lacunes, whereas hyperlipidae-
mia had a protective role. Recurrent lacunar infarction, 
especially in the case of  multiple episodes of  recurrent 
lacunes, may alert to the presence of  cognitive impair-
ment20. 
Ischemic stroke is a clinical syndrome with various ge-
netic and clinical risk factors including age, cholesterol, 
triglyceride, HDL-C, LDL-C and glucose. Case-control 
studies are commonly used to find the association be-
tween the risk factors and the complex human diseas-
es. A recent meta-analysis suggests that the association 
of  lipoprotein (a) and ischemic stroke is stronger for 
young adults aged <55 years than for older individuals21. 
A Dutch study showed a fourfold higher mortality for 
young patients with ischemic stroke compared to age and 
sex matched background population, with excess mortal-
ity present across all age groups, but particularly for those 
aged 35–50 years22. The best UK data on stroke project 
shows incidence rate for first stroke is 1.6 per 1000 per-
son years23. 
The presence of  sleep apnea is also a risk factor for stroke. 
Sleep apnea may increase the risk of  stroke by leading to 
or worsening hypertension or ischemic heart disease. As-
ymptomatic vascular disorders may be viewed as subclin-
ical arterial markers related to cardiovascular risk factors, 
Fig 4: Forest plots showing effect of Glucose and age on ischemic stroke.
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and are predictors of  stroke, myocardial infarction and 
vascular death in the mid- and long-term.24 
This meta-analysis examined all the available studies on 
the association between modifiable and non-modifiable 
risk factors and ischemic stroke risk, including a total of  
2611 ischemic patients and 2833 healthy control subjects. 
Although the pooled results showed that age, total cho-
lesterol, HDL-C and LDL-C were not associated with the 
risk of  ischemic stroke, the trend to an increased risk of  
developing ischemic stroke was observed due to high glu-
cose (P=0.01) and triglyceride levels (P=0.008). Regarding 
cholesterol and its components, an association between 
low high-density lipoprotein cholesterol and ischemic 
stroke at young age has been demonstrated 25-27 but 
no clear association has been shown for total cholester-
ol, low-density lipoprotein cholesterol, or triglycerides. 
However, we could draw an interesting conclusion from 
that the more studies were included; the higher risk of  de-
veloping ischemic stroke was indicated in the results. The 
overall heterogeneity between studies was very high for 
ischemic stroke risk factors like age, total cholesterol, tri-
glyceride, HDL-C, LDL-C and glucose levels as indicated 
by I2 value of  >95% and as such no publication bias was 
detected within studies included in the meta-analysis.  
This meta-analysis had some limitations. First, that only 
eight papers were included and also confounders were 
not included in the analysis, even though we tried to find 
as many studies as we could, assessed the literature care-
fully and used statistical methods to minimize the publi-
cation bias. Second, the number of  subjects involved in 
our meta-analysis was limited. Thus, studies with larger 
sample size and high quality are needed to demonstrate 
our conclusions in future.  
Conclusion  
Meta-analysis of  modifiable and non-modifiable risk fac-
tors like total cholesterol, high density lipid-cholesterol 
(HDL-C), low density lipid-cholesterol (LDL-C) and age 
were not independent risk factors for ischemic stroke; 
however triglyceride and glucose levels were proved as 
risk factors for ischemic stroke. Therefore present me-
ta-analysis identified the importance of  modifiable risk 
factors on ischemic stroke predisposition in Asian pop-
ulation.
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